(19)
(11) EP 0 122 712 A3

(12) EUROPEAN PATENT APPLICATION

(88) Date of publication A3:
14.05.1986 Bulletin 1986/20

(43) Date of publication A2:
24.10.1984 Bulletin 1984/43

(21) Application number: 84301652

(22) Date of filing: 12.03.1984
(84) Designated Contracting States:
AT BE CH DE FR GB IT LI LU NL SE

(30) Priority: 10.03.1983 US 473876
12.07.1983 US 512920

(71) Applicant: THE SALK INSTITUTE FOR BIOLOGICAL STUDIES
 ()

(72) Inventors:
  • Vale, Wylie Walker, Jr.
     ()
  • Rivier, Jean Edouard Frederic
     ()

   


(54) GnRH antagonists


(57) Peptides which inhibit the secretion of gonadotropins by the pituitary gland and inhibit the release of steroids by the gonads. Administration of an effective amount prevents ovulation of female mammalian eggs and/or the release of steroids by the gonads. The peptides have the structure: X-R1-R2-D-Trp-Ser-R5-R6-Leu-Arg-Pro-R1 wherein X is hydrogen or an acyl group having 7 or less carbon atoms; R, is dehydro-Pro, D-pGlu, D-Phe, D-Trp or β-D-NAL; R2 is Cl-D-Phe, F-D-Phe, CαMe-4-Cl--D-Phe, NO2-D-Phe, Cl2-D-Phe or Br-D-Phe; Rs is Tyr, l-Tyr, CH3-Phe, F-Phe or Cl-Phe; R6 is a D-isomer of a lipophilic amino acid or is 4-NH2-D-Phe, 4-gua-D-Phe, D-His, D-Lys, D-Orn, D-Har or D-Arg; and R10 is Gyl-NH2, D-Ala-NH2 or NH-Y, with Y being lower alkyl, cycloalkyl, fluoro lower alkyl or

where Q is H or lower alkyl. When R, is β-D-NAL, R6 is 4-NH2-D-Phe, 4-gua-D-Phe, D-His, D-Lys, D-Orn, D-Har or D-Arg. When R5 is Tyr or 2-Cl-Phe, either Orn, AAL or aBu is substituted for Ser, or R, is β-D-NAL and R6 is D-His or 4-gua-D-Phe. NαMe-Leu may optionally be substituted for Leu.





Search report